Statin Therapy for Hypertensive Patients

Indications for Statin Therapy

The European Society of Cardiology recommends statin therapy for hypertensive patients with established cardiovascular disease, type 2 diabetes, or an estimated 10-year cardiovascular mortality risk ≥5%, regardless of their baseline LDL-cholesterol level 1, 2
Established cardiovascular disease, such as coronary heart disease, peripheral artery disease, or previous stroke, is an indication for statin therapy in hypertensive patients 3
Type 2 diabetes mellitus is an indication for statin therapy in hypertensive patients 2
A 10-year cardiovascular death risk ≥5% based on the SCORE chart is an indication for statin therapy in hypertensive patients 1

The European Society of Cardiology recommends using the SCORE risk chart as a minimal requirement to calculate 10-year cardiovascular death risk in every hypertensive patient 1
Subclinical organ damage, particularly in patients at low-moderate risk with SCORE 1-4%, predicts cardiovascular death independently of SCORE and should be assessed in hypertensive patients 1

The ASCOT-LLA trial demonstrated that atorvastatin 10 mg reduced LDL-C by 42 mg/dL (29%) and reduced the primary endpoint of nonfatal MI + fatal CHD by 36% in hypertensive patients with ≥3 cardiovascular risk factors 4, 5
The ASCOT-LLA trial also demonstrated that atorvastatin 10 mg reduced fatal and nonfatal stroke by 27% and total cardiovascular events by 21% in hypertensive patients with ≥3 cardiovascular risk factors 4, 5
The Heart Protection Study demonstrated that simvastatin markedly reduced cardiac and cerebrovascular events in the hypertensive subpopulation, regardless of antihypertensive treatment type 3

The European Society of Cardiology recommends targeting LDL-C <2.5 mmol/L (approximately 97 mg/dL) for patients without atherosclerotic disease 2
The European Society of Cardiology recommends targeting LDL-C <1.8 mmol/L (approximately 70 mg/dL) using higher-dose statins for diabetic patients or those at very high cardiovascular risk 2
High-intensity statin options include atorvastatin 80 mg daily and rosuvastatin 20-40 mg daily 4, 6, 7
Moderate-intensity statin options include atorvastatin 10-20 mg daily, rosuvastatin 5-10 mg daily, simvastatin 20-40 mg daily, and pravastatin 40-80 mg daily 6, 7, 8

The European Society of Cardiology recommends low-dose aspirin for hypertensive patients with established cardiovascular events (Class I recommendation) 1
The European Society of Cardiology recommends considering antiplatelet therapy for hypertensive patients without cardiovascular history but with reduced renal function or high cardiovascular risk (Class IIb recommendation) 1

The American College of Cardiology/American Heart Association (ACC/AHA) recommends high-dose atorvastatin 80 mg daily for patients with acute coronary syndromes and established cardiovascular disease, which is applicable to a 67-year-old female patient with hypertension and history of chest pain, indicating possible coronary heart disease or angina 9

High-dose atorvastatin 80 mg is the standard recommendation for secondary prevention in patients with established cardiovascular disease, as suggested by the ACC/AHA guidelines 9

The American College of Cardiology recommends targeting LDL-C <70 mg/dL for patients with very high cardiovascular risk, which may be applicable to this patient 10

Strong evidence exists for the benefits of statin therapy in patients aged 40-75 years, which includes this 67-year-old patient 11

When initiating atorvastatin 80 mg, it is essential to monitor for myopathy and muscle symptoms, as well as hepatic toxicity, by checking liver function tests at baseline and as clinically indicated 9

The American College of Cardiology recommends blood pressure control to <140/90 mmHg (or <130/80 mmHg if diabetes is present) for patients with hypertension and cardiovascular disease 9, 10
Comprehensive evaluation of chest pain is necessary to determine if it represents angina or acute coronary syndrome, and smoking cessation should be considered if applicable 9, 10